From AstraZeneca to Sequoia. How to do business with China? Ring Hong Kong

The new buzzword is de-risking no more decoupling and launched it from the columns of the Financial Times the head of Raytheon, the American giant of radars and missiles (Tomahawk and Patriot are the best known). “If we had to leave China – explained Greg Hayes – it would take many many years to re-establish our production capacity both domestically and in friendly countries”. Raytheon has companies in China, a strong commercial activity, about two thousand direct employees. Not to mention the rare materials and metals he’s addicted to. So, your strategy is to reduce the risks, not the industrial and economic presence in the Middle Kingdom. To open a geopolitical umbrella, AstraZeneca has decided to split up and list separately in Hong Kong or Shanghai, following the example of Sequoia, the Californian venture capital company.